Skip to main content

Advertisement

SpringerLink
Log in

Assessment of coronary artery disease based on coronary flow velocity reserve by transthoracic Doppler echocardiography and coronary computed tomography angiography in a patient with dextrocardia: a case report

  • Case image in cardiovascular ultrasound
  • Published:
Journal of Echocardiography Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Elbasheer E, Habib A, Salam A. Primary angioplasty and later elective multivessel stenting in a patient with dextrocardia: a case report and literature review. J Invasive Cardiol. 2010;22:125–8.

    Google Scholar 

  2. Watanabe N. Noninvasive assessment of coronary blood flow by transthoracic Doppler echocardiography: basic to practical use in the emergency room. J Echocardiogr. 2017;15:49–56.

    Article  PubMed  Google Scholar 

  3. Watanabe H, Hozumi T, Hirata K, et al. Noninvasive coronary flow velocity reserve measurement in the posterior descending coronary artery for detecting coronary stenosis in the right coronary artery using contrast-enhanced transthoracic Doppler echocardiography. Echocardiography. 2004;21:225–33.

    Article  PubMed  Google Scholar 

  4. Nakanishi H, Hirata K, Tsujioka H, et al. Incremental value of coronary flow velocity reserve, measured by transthoracic echocardiography, compared with computed tomography angiography alone, for detecting flow-limiting coronary stenoses. J Am Soc Echocardiogr. 2014;27:1230–7.

    Article  PubMed  Google Scholar 

  5. Yoshitani H, Takeuchi M, Sakamoto K, et al. Effect of one or more co-morbid conditions on diagnostic accuracy of coronary flow velocity reserve for detecting significant left anterior descending coronary stenosis. Heart. 2005;9:1294–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Japan

    Kentaro Kakuta, Kaoru Dohi, Naoki Fujimoto & Masaaki Ito

  2. Department of Cardiology, JCHO Yokkaichi Hazu Medical Center, 10-8 Hazuyama, Yokkaichi, 510-0016, Japan

    Kentaro Kakuta, Takashi Yamanaka & Masaki Kawamura

Authors
  1. Kentaro Kakuta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kaoru Dohi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Naoki Fujimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Yamanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masaki Kawamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masaaki Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kentaro Kakuta.

Ethics declarations

Conflict of interest

Kentaro Kakuta received lecture fees from MSD K.K. Kaoru Dohi received lecture fees from AstraZeneca K.K., Astellas Pharma Inc., Abbott Japan Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Kowa Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., Fukuda Denshi Co., Ltd., Bristol-Myers Squibb, and Taisho Toyama Pharmaceutical Co., Ltd. Naoki Fujimoto received lecture from Eisai Co., Ltd. Takashi Yamanaka has no conflict of interest. Masaki Kawamura received lecture fees from Daiichi Sankyo Co., Ltd. Masaaki Ito received lecture fees from Pfizer Japan Inc., Daiichi Sankyo Co., Ltd., Astellas Pharma Inc., Chugai Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co., Ltd., Kowa Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Otsuka Pharmaceutical Co., Ltd., Actelion Pharmaceuticals Japan Ltd., Bristol-Myers Squibb, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Nippon Shinyaku Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Toa Eiyo Ltd. and Cook Japan, and received a research funding from Otsuka Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., Bristol-Myers Squibb, Asahi Kasei Medical Co., Ltd., Shionogi & Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Ono Pharmaceutical Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Daiichi Sankyo Company Limited, Torii Pharmaceutical Co., Ltd., and Mitsubishi Tanabe Pharma Corporation. The companies associated with this funding were not involved in the preparation of the manuscript or the decision to publish the present case report.

Funding

None.

Human rights statements and informed consent

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later revisions. The patient gave written informed consent for publication.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kakuta, K., Dohi, K., Fujimoto, N. et al. Assessment of coronary artery disease based on coronary flow velocity reserve by transthoracic Doppler echocardiography and coronary computed tomography angiography in a patient with dextrocardia: a case report. J Echocardiogr 16, 147–149 (2018). https://doi.org/10.1007/s12574-017-0367-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12574-017-0367-z

Keywords

Search

Navigation